DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kubitza D, Becka M, Wensing G, Voith B, Zuehlsdorf M.
Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects.
Eur J Clin Pharmacol 2005;
61 (12) 873-880
We do not assume any responsibility for the contents of the web pages of other providers.